| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8955869 | International Journal of Radiation Oncology*Biology*Physics | 2018 | 10 Pages |
Abstract
Radiation therapy efficacy at current standard RT doses for MCC is impaired among immunosuppressed patients with MCC. Although a strong link between durability of RT response and immune function does not appear to be evident in most cancers, our results may reflect an especially dynamic interaction between immune status and RT efficacy in MCC.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Yolanda D. MD, Macklin H. BS, Kelsey MS, Maclean BS, Mary PhD, Kristina MS, Shailender MD, Jay J. MD, Smith MD, Paul T. MD, PhD, Upendra MBBS, FRANZCR,